Literature DB >> 3558821

Impact of physical training on the ultrastructure of midthigh muscle in normal subjects and in patients treated with glucocorticoids.

F F Horber, H Hoopeler, J R Scheidegger, B E Grünig, H Howald, F J Frey.   

Abstract

Exercise-training might be a logical method to reverse muscle atrophy and weakness in patients treated with glucocorticoids. The purpose of the present investigation was to establish whether a treatment with low dose prednisone (10 +/- 2.9 mg/d) modulates the effect of a moderate strength type isokinetic training during 7 wk (21 sessions of 20 min) on "muscle efficiency" (power output/muscle mass) and on concomitant changes in ultrastructure of the thigh muscle measured by quantitative electron-microscopic morphometry. Training caused a similar increase in "muscle efficiency" in patients on prednisone (n = 9) as in normal volunteers (n = 9). In normal subjects the increase in muscle efficiency was associated with an increase in sarcoplasm, whereas in patients on prednisone the functional improvement was associated with an increase in sarcoplasm, capillaries, and mitochondria content. Thus, a therapy with low dose prednisone does not abrogate training-induced improvement of muscle efficiency but modulates the ultrastructural response of the muscle to the training.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558821      PMCID: PMC424305          DOI: 10.1172/JCI112935

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Studies in disorders of muscle. XII. Myopathy due to the administration of therapeutic amounts of 17-hydroxycorticosteroids.

Authors:  G T PERKOFF; R SILBER; F H TYLER; G E CARTWRIGHT; M M WINTROBE
Journal:  Am J Med       Date:  1959-06       Impact factor: 4.965

2.  The nature of the intermediate tetrapyrroles in protoporphyrin and heme biosynthesis.

Authors:  L ERIKSEN
Journal:  Scand J Clin Lab Invest       Date:  1962       Impact factor: 1.713

3.  Estimation of creatinine by the Jaffe reaction. A comparison of three methods.

Authors:  H Husdan; A Rapoport
Journal:  Clin Chem       Date:  1968-03       Impact factor: 8.327

4.  Steroid myopathy. Clinical, histologic and cytologic observations.

Authors:  A K Afifi; R A Bergman; J C Harvey
Journal:  Johns Hopkins Med J       Date:  1968-10

5.  Altered skeletal muscle ultrastructure in renal transplant patients on prednisone.

Authors:  F F Horber; H Hoppeler; D Herren; H Claassen; H Howald; C Gerber; F J Frey
Journal:  Kidney Int       Date:  1986-09       Impact factor: 10.612

6.  Muscle performance, morphology and metabolic capacity during strength training and detraining: a one leg model.

Authors:  M E Houston; E A Froese; S P Valeriote; H J Green; D A Ranney
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1983

7.  Biochemical and ultrastructural changes of skeletal muscle mitochondria after chronic electrical stimulation in rabbits.

Authors:  H Reichmann; H Hoppeler; O Mathieu-Costello; F von Bergen; D Pette
Journal:  Pflugers Arch       Date:  1985-05       Impact factor: 3.657

8.  Electron microscopic observations in thyrotoxic and corticosteroid-induced myopathies.

Authors:  A G Engel
Journal:  Mayo Clin Proc       Date:  1966-11       Impact factor: 7.616

9.  Neural factors versus hypertrophy in the time course of muscle strength gain.

Authors:  T Moritani; H A deVries
Journal:  Am J Phys Med       Date:  1979-06

10.  Light microscopic study of striated muscle in uremia.

Authors:  R E Ahonen
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

View more
  14 in total

1.  Exercise interest and preferences among patients diagnosed with primary brain cancer.

Authors:  Lee W Jones; Bebe Guill; Stephen T Keir; Karen Carter; Henry S Friedman; Darell D Bigner; David A Reardon
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

Review 2.  Exercise following heart transplantation.

Authors:  R W Braith; D G Edwards
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

3.  Human growth hormone prevents the protein catabolic side effects of prednisone in humans.

Authors:  F F Horber; M W Haymond
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 4.  Steroid myopathy: some unresolved issues.

Authors:  M A Minetto; F Lanfranco; G Motta; S Allasia; E Arvat; G D'Antona
Journal:  J Endocrinol Invest       Date:  2011-05       Impact factor: 4.256

5.  Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma.

Authors:  Lee W Jones; Allan H Friedman; Miranda J West; Stephanie K Mabe; Jennifer Fraser; William E Kraus; Henry S Friedman; Maura I Tresch; Nancy Major; David A Reardon
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

6.  Resistance training alters skeletal muscle structure and function in human heart failure: effects at the tissue, cellular and molecular levels.

Authors:  Michael J Toth; Mark S Miller; Peter VanBuren; Nicholas G Bedrin; Martin M LeWinter; Philip A Ades; Bradley M Palmer
Journal:  J Physiol       Date:  2011-12-23       Impact factor: 5.182

Review 7.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

Review 8.  Exercise and heart transplantation. A review.

Authors:  G Niset; L Hermans; P Depelchin
Journal:  Sports Med       Date:  1991-12       Impact factor: 11.136

Review 9.  Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential.

Authors:  Valeria Ferrero; Flavio Ribichini; Gabriele Pesarini; Sandra Brunelleschi; Corrado Vassanelli
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module.

Authors:  Karin Piil; Meagan Whisenant; Tito Mendoza; Terri Armstrong; Charles Cleeland; Sara Nordentoft; Loretta A Williams; Mary Jarden
Journal:  Neurooncol Pract       Date:  2020-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.